Sort   by:  
 Page size 
TranscriptomicsMicroRNA profiling by array of human stage I epithelial ovarian cancer
In an effort to define the biological determinants of stage I chemo-sensitivity, we undertook a genome-wide miRNA expression profile in a cohort of 89 stage I patients (24 of which relapsed) with a complete follow up of twelve years, selected from a single tumor tissue collection of more than 1300 s...
ORGANISM(S): Homo sapiens 
2010-12-31 | E-MTAB-297 | biostudies-arrayexpress
TranscriptomicsTranscriptional profiling of the MV4-11 cell line treated with trabectidin or azacitidin
In order to study the effects of trabectedin in chronic myelomonocytic leukemia and in juvenile myelomonocytic leukemia, we performed whole genome transcriptional profiling of a model cell line treated under either the reference drug for CMML / JMML (Azacitidine) or trabectedin.
ORGANISM(S): Homo sapiens 
2016-12-14 | E-MTAB-2978 | biostudies-arrayexpress
TranscriptomicsmicroRNA profiling of ovary cell tumors and HOSE cells
In order to determine the difference at the microRNA level of different ovarian tumor histotypes, we have performed a whole miRNA screening on 183 patients of grade 1 ovarian cancer. Additionally, we compared the miRNA profile of tumors with standard ovarian epithelial cells (HOSE).
ORGANISM(S): Homo sapiens 
2013-06-17 | E-MTAB-1067 | biostudies-arrayexpress
TranscriptomicsGene expression profile of primary and relapsed epithelial ovarian cancer
Not available
ORGANISM(S): Homo sapiens 
2012-09-15 | E-MTAB-611 | biostudies-arrayexpress
TranscriptomicsComparison Between Gene Expression Profiles of Sensitive and Resistant Trabectedin Liposarcoma Cell Lines
Gene expression profiles of 402-91 FUS-CHOP type I cells have been compared to 402-91/ET cells made resistant to Trabectedin Experiments were performed on purified RNA from independent batches of 402-91 and 402-91/ET cells without drug treatment.
ORGANISM(S): Homo sapiens 
2010-07-13 | E-GEOD-20350 | biostudies-arrayexpress
Sort   by:  
 Page size